ArticlePediatric nephrology (Berlin, Germany)2025

Obinutuzumab as a viable therapeutic strategy in rituximab-refractory childhood frequently relapsing, steroid-dependent nephrotic syndrome that relapsed during B-cell depletion.

Eugene Yu-Hin Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.